Phytopharms press release on their clinical studies in P57
On 5th December 2001, Phytopharm announced the successful completion of the third and final stage on their proof of principle, clinical study, of the molecule named P57. This press release states that P57, is patented by Phytopharm and is under development as an appetite suppressant for the treatment of obesity and related conditions.
The object of [...]
